Clarus Therapeutics Inc. (CRXT)
NASDAQ: CRXT
· Real-Time Price · USD
0.05
-0.02 (-27.54%)
At close: Sep 06, 2022, 7:59 PM
Clarus Therapeutics Revenue
Clarus Therapeutics reported an annual revenue of $13.96M, reflecting a undefined% growth. For the quarter ending June 30, 2022, Clarus Therapeutics generated $4.05M in revenue.
Revenue (ttm)
-
Revenue Growth
undefined%
Price / Sales Ratio
undefined
Revenue / Employee
-
Employees
undefined
Market Cap
0
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|